β-blockers reduced the risk of 60-day composite endpoint (HR, 0.71; 95% CI, 0.55–0.91), but their protective effect on re-hospitalization (HR, 0.75; 95% CI, 0.55–1.01) and mortality (HR, 0.67; 95% CI, 0.45–1.01) did not reach statistical significance.
← all excerpts
Prognostic Effect of Guideline-Directed Therapy Is More Noticeable Early in the Course of Heart Failure.
1
—
—